Neuroendocrine Tumor G2 — Trials

Neuroendocrine Tumor G2 — Trials · CancerIndex

Clinical trials

Registered studies

20 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

clinicaltrialsPublishedShowing 1–6 of 6 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT03375320	Testing Cabozantinib in Patients With Advanced Pancreatic Neuroendocrine and Carcinoid Tumors	active not recruiting	Phase 3	298	National Cancer Institute (NCI)NIH	1	Sep 22, 2026	clinicaltrials
NCT00569127	Octreotide Acetate and Recombinant Interferon Alfa-2b or Bevacizumab in Treating Patients With Metastatic or Locally Advanced, High-Risk Neuroendocrine Tumor	active not recruiting	Phase 3	427	National Cancer Institute (NCI)NIH	1	Aug 28, 2026	clinicaltrials
NCT01841736	Pazopanib Hydrochloride in Treating Patients With Progressive Carcinoid Tumors	active not recruiting	Phase 2	171	National Cancer Institute (NCI)NIH	2	Aug 28, 2026	clinicaltrials
NCT03110978

Data updated 5 days agoSource updated Sep 22, 2026source: clinicaltrials